Cambridge, UK: TAP Biosystems (now part of the Sartorius Stedim Biotech Group), a leading supplier of innovative cell culture and fermentation systems for life science applications, is delighted to announce that TAP Biosystems and Merck have been nominated as co-finalists for two awards at the prestigious 2014 BioProcess International (BPI) Awards. The nominations recognise that the ambr250™ System, developed as a result of the collaboration, is a major advance in bioprocessing technology.
At the BioProcess International Awards, TAP Biosystems and Merck have been selected as finalists in the ‘Best Collaboration Award’ and the ‘Best Technology Application — Upstream Award’ categories from amongst numerous outstanding industrial collaborations for their partnership to develop the powerful ambr250 automated mini bioreactor system.
The high-throughput ambr250, co-developed with Merck, has the flexibility to culture mammalian lines, including CHO, or microbial cells, such as Pichia pastoris and E.coli, in single-use, stirred bioreactors utilising continuous pumped feeds. This means using the ambr250 it is now possible to fully evaluate the process characteristics of large-scale bioreactors and fermenters in weeks rather than months, making the system a significant breakthrough in bioprocessing technology.
For details of all the finalists in the 2014 BPI awards, please go to http://www.bioprocessintl.com/wp-content/uploads/2014/10/BPI-Awards_Finalists_2014.pdf
Mwai Ngibuini, ambr250 Product Manager at TAP Biosystems commented: “We’re honoured to be shortlisted with Merck for not one, but two BPI awards from such an amazing line-up of bioprocessing advances. Being recognised in these celebrated awards is a great accolade, and further supports the use of ambr250 technology as an excellent strategy for optimising production of antibody and protein-based therapeutics to pharma and biotech world-wide.” -Ends- For Further Information Contact: Michaela McAdam, Marketing Communications Manager, TAP Biosystems, York Way, Royston, Hertfordshire, SG8 5WY, UK. Tel: +44 (0) 1763 227200 Fax: +44 (0) 1763-227201 Email:Michaela.mcadam@tapbiosystems.com Web: www.tapbiosystems.com Twitter: @TAPBiosystems
Editor Contact:
Dr. Sue Pearson, Director, International Science Writer, PO Box 170, Hitchin, Hertfordshire, SG5 3GD, UK. Tel/Fax + 44 (0) 1462-635327 Email: sue.pearson@internationalsciencewriter.com Web: www.internationalsciencewriter.com Twitter: @ISciencewriter
Note to Editors
About TAP Biosystems
TAP Biosystems (now part of the Sartorius Stedim Biotech Group) is a leading global provider of automated cell culture and fermentation systems for life science research, development and production. TAP’s systems are in use worldwide at pharmaceutical, biotechnology and academic laboratories, supporting bioprocess development and GMP manufacture of biologics and cell therapies, as well as discovery and stem cell research programmes.
Founded in 1987, the company has offices in the UK and USA, and an extensive network of distributors in Europe and Asia offering pre- and post-sales support. www.tapbiosystems.com
Help employers find you! Check out all the jobs and post your resume.
